z-logo
open-access-imgOpen Access
LncRNA HCG18 Promotes Clear Cell Renal Cell Carcinoma Progression by Targeting miR-152-3p to Upregulate RAB14
Author(s) -
Yang Yu,
Pengfeng Gong,
Dongwei Yao,
Dong Xue,
Xiaozhou He
Publication year - 2021
Publication title -
cancer management and research
Language(s) - Uncategorized
Resource type - Journals
ISSN - 1179-1322
DOI - 10.2147/cmar.s298649
Subject(s) - clear cell renal cell carcinoma , gene knockdown , cancer research , gene silencing , viability assay , downregulation and upregulation , cell growth , cell , luciferase , rna interference , microrna , biology , microbiology and biotechnology , chemistry , cell culture , renal cell carcinoma , medicine , transfection , oncology , rna , gene , biochemistry , genetics
Long noncoding RNAs (lncRNAs) have been regarded as crucial regulators in many cancers, including clear cell renal cell carcinoma (ccRCC). This research aimed to explore the biological role and molecular mechanism of lncRNA HCG18 in ccRCC.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here